Related by context. All words. (Click for frequent words.) 78 xvii 76 xv 73 xviii 71 xii 71 xiii 71 viii 70 xxii 70 xiv 70 xix 69 xxi 68 vii 68 ix 66 xxv 65 iv 64 iii 63 xxvii 63 xxvi 63 xxiv 62 xxiii 62 xi 58 xxviii 58 vi 58 Immtech clinical trials 58 ii 53 risksassociated 52 xxxii 52 ourability 52 unanticipated difficulties 51 collect reinsurance recoverables 51 legal proceedings xxi 51 Pure Biofuels ability 51 Immtech scientists 50 xxxiii 50 substantial indebtedness 50 inventory obsolescence 49 xxxi 49 general economicconditions 49 multiple lease terminations 49 incurrence 49 risks associatedwith 49 ability tosuccessfully 48 regarding Heska 48 affecting Amarin 48 xvi beer 48 retrocessional coverage 48 economicconditions 48 personnel xvii inability 48 xv licensing 48 materially adversely affect 48 orother 48 changesin 48 i# implanters 48 incur unanticipated 47 vii IBC 47 requirements xxii 47 VIOXX Lawsuits 47 vii viii 47 related thereto 47 xiv licensing 47 governmental approvals 47 without limitation 47 Unitholder liability 47 DSL.net s 47 HANA MAX 47 representations warranties covenants 47 successfully integrate 47 d Represents 47 unanticipated 46 market fluctuations investee 46 adverse determinations 46 xxix 46 including withoutlimitation 46 withrespect 46 Projects Initiation 46 § #.#-# [004] 46 communicate differentiations effectively 46 contingent guaranties 46 unitholder liability 46 TranSwitch indebtedness 45 technological obsolescence 45 personnel xviii inability 45 Crisa acquisition 45 tenant bankruptcies 45 ICT GROUP 45 causeactual results 45 affirmative covenants 45 work stoppages quarantines 45 ourproducts 45 statementsregarding 45 date xvii Conversion 45 SURETY LICENSES c 45 CAUTION ANY ATTEMPT 45 maydiffer materially 45 anduncertainties 45 SumTotal Systems filings 45 orotherwise 45 tarmac strandings Hanni 45 d Reflects 45 theCompany 45 affecting mortality morbidity 45 impactof 45 § #.#-# [007] 45 [013] 44 consummating acquisitions 44 prepayment speeds loan originations 44 -#,# -#,# -#,# -#,# [003] 44 otherfactors 44 VELCADE therapy 44 expenses associated therewith 44 Thalomid R 44 iii iv 44 lender consents 44 #.#-# b [001] 44 assorted pigments resins 44 risks anduncertainties 44 early extinguishments 44 theability 44 #.#-# b [002] 44 SeraCare competitors 44 acquisitions dispositions 44 obtaining regulatory approvals 44 PharMerica LTC Transaction 44 adversely affecting Cubist 44 HealthGate ability 44 sites xix limitations 44 without limitation Terremark 44 notlimited 44 depreciation depletion amortization 44 relatedto 44 vii Dynamic 44 adversely affect Waste Connections 44 f h 43 #.# subd [003] 43 GEROVA underwrites insurance 43 adversely affect 43 otherrisks 43 risks unanticipated reclamation 43 mergers consolidations 43 prices drydocking 43 nonoccurrence 43 pricing pressures 43 associatedwith 43 reinsurance recoverables owed 43 § #-#-# b [003] 43 -DEAD BODY 43 Equinix filings 43 Merger Transactions 43 thereto 43 suchforward looking 43 filingswith 43 Excluding acquisitions divestitures 43 Offerors Commercial applies 43 thereby negatively impacting 43 risks associated 43 party VLSI fabrication 43 permitting timelines 43 ADSI reliance 43 areforward looking 43 CFR #.#b 43 fluctuations cyclicality 43 c Relates 43 diminishing quantities 43 h r 43 EPIXTAR 'S 43 marketconditions 43 ceded reinsurance 43 Black Canyon mica 43 work stoppages slowdowns 43 limitedto 42 acquisitions divestitures joint ventures 42 risksand uncertainties 42 #.#-# Equal Opportunity 42 visit http:/www.nationwide.com 42 PLIVA acquisition 42 MTI MTI Micro 42 delinquencies defaults 42 ultimate recoverability 42 #,#,# Deferred [002] 42 Refinancing Transactions 42 § #-#-# [005] 42 § #-#-# b [001] 42 expropriation nationalization 42 USC § #a [002] 42 #,#,# Commitments 42 Colo. Sess 42 relating 42 regulations xvii 42 y u 42 EMPOWER pivotal trial 42 results ofoperations 42 differ materiallyfrom 42 rapid technological 42 USC § #u 42 Legal #.# 42 technology crystalline ingot 42 i #.# subds 42 uncertainties materialize Shire 42 natural disasters pandemics 42 materially differ 42 may diverge numerically 42 n h r 42 contingently liable 42 deploy MDCE services 42 - -Billeaudeau 42 arenot limited 42 amendments thereto 42 worsening peripheral neuropathy 42 intercompany arrangements 42 b Represents 42 Textainer expectation 42 uncertainties materialize Shire plc 41 differ materially 41 postretirement benefit plans 41 product introductions 41 Fourth Supplemental Indenture 41 Consists primarily 41 technological innovations adversely affecting 41 obsolete inventory 41 DTR #.#.# b 41 Form 8K #K 41 involve risksand uncertainties 41 acquisitions divestitures 41 JLG acquisition 41 b Excludes 41 NJSA #:#-# [004] 41 differmaterially 41 risks associated therewith 41 Shire plc Attention Deficit 41 Prospective Bidder may 41 LAE reserves 41 xv adverse 41 h y 41 non capitalizable 41 cranes Fuchs 41 aresubject 41 manufacture PolyHeme 41 OSI Pharmaceuticals filings 41 productsand services 41 customers licensees licensors 41 Partially offset 41 viii insufficient 41 P. #a 41 - Operating [025] 41 Heska reliance 41 surety bonding increased 41 natural disasters epidemics 41 unanticipated geological 41 affecting IsoTis 41 impacting WesBanco 41 EAHA shall automatically 41 c SIGA 41 market PolyHeme commercially 41 - Loss [020] 41 FierceGovernmentIT tracks 41 materially adversely affected 41 Yima project 41 i g 41 REIT xi 41 § #.# [004] 41 c Excludes 41 purchaserâ € ™ 41 competitively procured pursuant 41 Nortek Holdings 41 fluctuations 41 timing rescheduling 41 website www.gladiatorstocks.com 41 acquisitions divestitures restructurings 41 Item IA 41 b Relates 41 BY AN ENTRANT 41 ARLP Partnership 41 sites xviii limitations 41 credit carryforwards 41 toreflect 41 involve risks anduncertainties 41 unconsolidated investees 41 SmarTire dependence 41 Kronos TiO2 41 securityholder approvals 41 PGP Acquisition 41 Income Tax Regs 41 xiv unanticipated 41 xxvi introduction 41 adversely affect Univest Corporation 40 periodic redeterminations 40 workersa compensation 40 CompX 40 heading RISK FACTORS 40 h g 40 Lasertel subsidiary 40 xii trademark 40 Candente relies upon 40 Repl. 40 unscheduled outages 40 AUCTIONEER CONSIGNOR OR 40 RR Donnelley periodic filings 40 Bioenvision filings 40 u t 40 couldcause 40 intercompany indebtedness 40 Form #KSB filed 40 See USSG § #B#.# 40 Securities andExchange Commission 40 postretirement benefit obligations 40 renegotiation nullification 40 uncertainties 40 Terremark filings 40 Bo Scaife TE 40 Auxilium anticipates 40 dispositions 40 economically recoverable coal 40 Company noncontributory defined 40 shipper ie 40 illiquid restricted 40 Subparagraph 40 Discontinued Operations Including 40 -#,# -#,# [002] 40 OneBeacon filings 40 Favrille filings 40 difficulties foreseeing 40 excludes depreciation amortization 40 title taxation sociopolitical 40 USC § #f 40 #,#,# #,#,# Commitments [002] 40 asset impairments 40 SANCTURA SANCTURA XR VANTAS 40 Healthvision acquisition 40 currency fluctuations imprecision 40 constituteforward looking 40 Iusacell Celular 40 constitutes discloseable transaction 40 - Loss [021] 40 postretirement benefit 40 #,#,# #,#,# -LAS VEGAS MGM Resorts 40 Market Disruption 40 dd DISCOUNTS R 40 NxStage anticipates 40 uncertaintiesthat 40 theseforward looking 40 postretirement benefits 40 assume NO RESPONSIBILITY 40 Johnell O 40 PLAVIX R patent 40 InfoSearch filings 40 BioSante licensees 40 proprietary Capillary Aerosolization Technology 40 intellectual property litigations 40 commercialize ZYFLO CR 40 Web site http:/www.EmergingStockReport.com 40 - -seemingly unquenchable 40 - OperAyscough 40 HF Lenfest member 40 p r 40 liabilities slippage 40 Sepracor anticipates 40 Secure Computing periodic 40 Proposed Financing 40 OTHER INCOME EXPENSES 40 u h 40 differ materially fromthose 40 retrocessional reinsurance 40 merchant chargebacks 40 reasonably determinable 40 ExchangeCommission 40 suchstatements 40 website www.FreePennyAlerts.com 40 TRISENOX R 40 recompetes 40 r l 40 adversely affect Hologic 40 Invitel Holdings operates 40 Prelude SkinPrep Systems 40 OCGA § #-#-#.# 40 associated therewith 40 especially Copaxone ® 40 SUPPRELIN LA DELATESTRYL 40 TeamStaff GS 40 Lordsburg Mining District 40 FGIC insured 40 Atheros Quarterly Report 40 g o 39 materially impair 39 OMNI dependence 39 TranSwitch filings 39 #,#,# Deferred [001] 39 #.# subd [004] 39 LocatePLUS Statements 39 Varvarinskoye Project 39 w # yQ 39 CompAir acquisition 39 Risks uncertainties 39 forwarda ^ looking 39 CFR § #.# [006] 39 Second Supplemental Indenture 39 EHSK 39 EDGAR Online via COMTEX 39 incidental thereto 39 Beneficial Ownership 39 -Laemmle Music 39 currency fluctuation 39 concerning AudioCodes 39 SANCTURA SANCTURA XR NEBIDO 39 indebtedness covenant 39 FSAH 39 Receivable purchasing 39 sublease recoveries 39 #.# subds [002] 39 radiological NBCR 39 xiii trademark 39 Company periodic filings 39 mergers dispositions 39 n h 39 forward lookingstatements 39 FAFLIC 39 Prospectuses contain 39 EFFECT OF FOREIGN CURRENCY 39 borrower depositor 39 cancellations rescheduling 39 refinance indebtedness 39 SearchHelp communications 39 RISKS AND UNCERTAINTIES 39 TCA § #-#-# [003] 39 #.#-# [016] 39 Kung sila pa rin 39 noticeably thinner stark 39 candidate Ramoplanin 39 cause actualresults 39 ADSI ability 39 tomaintain 39 Oligator R oligonucleotides iv 39 Congoleum undertakes 39 Proposed Transactions 39 - - [092] 39 VimpelCom disclaims 39 involverisks 39 LogicVision disclaims 39 Note Copper Equivalent 39 accounting pronouncements 39 CFR § #.# [004] 39 currency fluctuations 39 positive inotropic agents 39 maycause actual results 39 #.#A [005] 39 vendor unseasonable weather 39 reestimates 39 #.#-# Combating Trafficking 39 ecotoxicity 39 iii Cubist 39 e h r 39 execute supplemental indenture 39 - - Income [012] 39 ore densities 39 #.#-# #.#-# #.#-# #.#-# 39 drydocking 39 b Reflects 39 DELETE OR EDIT COMMENTS 39 Regulation XXX 39 Julius Peppers DE 39 BiDil XR drug 39 forward lookingstatement 39 DFAR #.#-# 39 variable annuity guarantees 39 @ y qW 39 OraTest R 39 Midwest Consent Decree 39 Reported Unaudited Condensed 39 MicroTel 39 joint ventures strategic alliances 39 retain drilling rigs 39 Variable annuities involve 39 hurricanes earthquakes 39 subjectto 39 Insolvency Proceedings 39 Inventory write downs 39 gli di 39 #.# subd [006] 39 constitute discloseable transaction 39 Sponsored REITs 39 Lenfest ii 39 factors thatcould 39 indentures pursuant 39 factorsthat 39 h u 39 - Operating [007] 39 = Adjusted [002] 39 reinsurance recoverable 39 unproved reserves 39 CompanyaEUR TM s 39 VIACOM INC. AND SUBSIDIARIES 39 executed supplemental indenture 39 DARA intellectual property 39 thereof 39 GrowthWorks refers 39 y h 39 servicemark risks xiv 39 depreciation accretion 39 l o 39 Bazet France 39 heading ITEM 1A 39 Ferlay J et al 39 futureresults 39 Master Commutation Release 39 #,#,#,#,# [010] 39 conditional verb tenses 39 #,# -SPIN BOLDAK Afghanistan 39 punitive incidental 39 - Commitments [011] 39 -Ewurun 39 AvenEx 39 SHAREHOLDER 'S EQUITY 39 ofsuch 39 PXRE undertakes 39 GulfMark filings 39 g Represents 39 customary representations warranties 39 - Loss [019] 39 attribution authenticity provenance 39 financialstatements 39 website StockPreacher.com 39 Acorda Therapeutics intellectual property 38 concerning Alexza 38 Sunesis clinical trials 38 thispress release 38 Restated Revolving Credit 38 Repligen filings 38 - - [085] 38 PDI periodic filings 38 Consists 38 drawing painting gouache 38 c Reflects 38 t h r 38 ecommerce marketplaces 38 QSGI offsets 38 redesigned website spokesman.com 38 - -Commey 38 promulgated thereunder 38 SEK -#.# -#.# [003] 38 andother 38 expenses LOE 38 arising therefrom 38 Restated Declaration 38 Probable 2P 38 reflect iSIGN Media 38 PolyHeme successfully 38 Unanticipated 38 o h 38 regardingthe 38 AspenTech periodic reports 38 #.#-# [005] 38 OREO valuation 38 website www.PennyStockAlley.com 38 t r 38 La.Code Crim.P. art 38 Colihues tailings impoundment 38 transportation storage terminalling 38 unfavorable geologic 38 Statement Statements 38 escalation unavailability 38 § #a [002] 38 OTI Annual Report 38 CFR #.# [006] 38 incorporated therein 38 Bioenvision dependence 38 excluding drydocking 38 Absentee bids shall 38 Baqoubah north 38 infringement invalidity 38 LOUIS Oshiomogho Atogwe 38 NASD Marketplace Rule 38 i# implanter 38 OCGA § #-#-# [005] 38 visit http:/www.tronox.com 38 e# periodic 38 VIOXX Product 38 xxiv adverse effects 38 #.#-# [001] 38 xxiii fluctuations 38 propres 38 vii Cubist ability 38 nondischargeability 38 site www.buyins.net 38 affect Petroflow 38 -Edelsberg 38 USC § #a [001] 38 est que 38 #.#-# Evaluation Commercial 38 - Expenses [006] 38 distinguishing GigaBeam products 38 subsequent amendments thereto 38 Goodwill impairment charge 38 website StockMarketLife.com 38 Shire Attention Deficit 38 #,#,# #,#,# Commitments [003] 38 - Segment [005] 38 Cerro Negro concession 38 franking credits attached 38 #,#,# #,#,# #,#,# #,#,# [001] 38 CAUTIONARY STATEMENT Statements 38 cash fl ows 38 theSecurities 38 uncertainties materializes FICO 38 party semiconductor foundries 38 IMPAX filings 38 mortality persistency 38 Charlie Manuel flips 38 r h 38 Risks Related 38 supplemental indenture containing 38 Pharmion Quarterly Report 38 prepayment speeds loan 38 - Operating Expenses [001] 38 Reinsurance recoverables 38 taxation socio 38 ProPhotonix 38 Certain Factors Affecting 38 connection therewith 38 MGCD# MGCD# [001] 38 website GreenGainers 38 f o 38 thereunder 38 c Consists 38 #,#,# #,#,# -shameful betrayal 38 Vion Form 38 -#,# [002] 38 vQsQn 38 g r 38 Non GAAP adjustments 38 l u 38 qW 38 theimpact 38 minesites 38 Zemiva TM Trofex TM 38 ` @ gn 38 d h 38 CORLUX CORT # 38 b Vernon Supp 38 should consult NeurogesX 38 transactions contemplated 38 -Crohn disease rheumatoid arthritis 38 - Total noninterest [010] 38 Thomas Regout operations 38 Verenium dependence 38 y r 38 affecting Pennichuck Corporation 38 intangible asset impairments 38 Waratah Coal filings 38 calcium hypochlorite markets 38 debt extinguishments 38 Au ozs 38 uninsurable risks 38 - Non GAAP [002] 38 professionals technological obsolescence 38 ii Immtech ability 38 APPY believes 38 § #-#-#.# 38 cturing 38 anyforward looking 38 deCODE filings 38 impair Lillian Vernon 38 # subd 38 ourbusiness 38 MOSAID litigation 38 Disruptions uncertainty 38 render PolyHeme obsolete 38 #,# -INDUSTRIES INC. 38 Mitsue Pipelines 38 geology continuity 38 Consent Letter 38 - IncoAdministración Nacional 38 Company nanocrystalline materials 38 DISMISSED WITH PREJUDICE 38 DIP Loan 38 historicalfacts 38 Oxandrin 38 love veronica Mars 38 - Income [033] 38 Fampridine SR Acorda Therapeutics 38 Carolinas Unfavorable primarily 38 g h 38 SILENOR ™ 38 attaching thereto 38 CASH FLOWS USED IN 38 arising 38 premium jackups 38 See USSG § #A#.# 38 bulk amorphous alloys 38 Theseforward looking 38 CholeraGarde R Peru 38 restrictive covenants contained 38 dispositions financings 38 majeure 38 shipping packing crating 38 DJO Merger 38 Profile Research AMXL.MX Quote 38 See USSG § #D#.# 38 r t 38 #,#,# #,#,# Deferred [002] 38 ` rk 38 CDO financings 38 contingencies 38 Section #/#K 38 wv ` 38 - Adjusted [017] 38 Proposed Arrangement 38 realizability 38 NNL failure 38 NYCRR #.# [003] 38 o l 38 PrivateSecurities Litigation Reform Act 38 molecular immunohematology products 38 Enpath ability 38 Miraculins cautions 38 Pharmos filings 38 #.# #.#.# 38 andoperating 38 - Commitments [007] 38 documentation evidencing 38 ADA CS 38 Newtek beliefs 38 capture exosomes 38 NJAC #:#-#.# 37 servicemark risks xiii 37 AudioCodes filings 37 Innotrac Website www.innotrac.com 37 KSA #-# [001] 37 cause actual 37 Omtool periodic reports 37 inaccurately estimating 37 unforeseen underperformance 37 Exelbine 37 carryforwards 37 Financing Condition 37 Publication Classified Ad 37 Fabrinet focuses 37 enforce MOSAID 37 l h 37 resins polymers 37 Somaxon ability 37 Manufacturer OEM 37 Convertible Subordinated Debt 37 concerning Wowjoint 37 therefrom 37 thepotential 37 please visit www.advantex.com 37 AngelCiti expectations 37 TFC receivables 37 equity accounted investees 37 persistency mortality 37 SemGroup LP SemGroup 37 Income Taxes Allocable 37 discontinued operations - 37 LDK Solar filings 37 - OperatiMcGrath RentCorp 37 pricing IMPAX 37 e mail jloewenstein@thedailyreview.com 37 performance compliances certifications 37 Gottschalks Annual Report 37 concerning Epigenomics AG 37 Questcor intellectual property 37 hereof shall 37 eCOST 37 offerings visit www.balqon.com 37 molecular immunohematology 37 subparagraph B 37 CFR § #.# [008] 37 Absentee Telephone 37 cause actual resultsto 37 - Non GAAP [004] 37 EVIZON TM squalamine lactate 37 CFR #.# [002] 37 § #-#.# [003] 37 BlackPearl Announces 37 Multiemployer Pension Plan 37 unfavorable variances 37 Liability Lawsuits 37 BioGlue ® 37 rights xix xx 37 Polo Jeans Company 37 consiste en 37 xi unanticipated 37 Infor expressly disclaims 37 Jupiterimages respective 37 eTelcharge.com Inc. 37 SciClone filings 37 supplemental indenture effecting 37 vi vii 37 w l 37 dispositions joint ventures 37 Idenix anticipates 37 - Income [018] 37 amort 37 #.# subds [001] 37 Laurion cautions against 37 Agreement constitutes discloseable 37 CommVault beliefs 37 inaccurate transmittal 37 inherent uncertainty 37 Varian Semiconductor dependence 37 hyperinflationary environments 37 Dimension BST 37 rapamycin derivatives 37 XP# XP# 37 - Total [037] 37 iv unanticipated 37 mw http :/ finance.yahoo.com 37 affecting O2Micro 37 Increases Bought Deal 37 LOPROX R 37 § #c 37 ARPU CPGA 37 withinthe meaning 37 tal li 37 principally attributable 37 CFR § #.# [005] 37 l w 37 consiste 37 informa 37 LPT Agreement 37 Diomed disclaims 37 § #.# subd [005] 37 andrelated 37 #,#,# #,#,# -DH Ellis Burks 37 adopting SFAS #R 37 couldcause actual results 37 Alnylam dependence 37 unfavorable fluctuation 37 morbidity mortality persistency 37 Convertible Notes tendered 37 Chase Kishner 37 forward.looking statements 37 § #A.# 37 Subscription Fulfillment Services 37 prepetition liabilities 37 className nodes nodes.length = 37 - -champioship 37 Subordinate MBS 37 OOK ETF 37 Yucheng filings 37 Western Keltic shareholders 37 INACCURACIES 37 reflect Ronn Motor 37 EcaFlo TM 37 pandemics impacting 37 ZERUST R 37 looking statementsâ € 37 forwardlooking statements 37 TrueKnowledge Platform TM 37 deviates materially 37 f Represents 37 c Represents 37 PMACIC 37 unconsolidated subsidiaries 37 statements ofhistorical fact 37 Zi OEM 37 antidumping rulings 37 infringed misappropriated invalid 37 nylon textured yarns 37 Risks Factors 37 h o 37 counterparty creditworthiness 37 reinsurance ceded 37 #.#-# Instructions 37 GoFish periodic filings 37 looking statementsare 37 STAAR assumes 37 MultiCell bases 37 OR LOSS 37 Silver Wheaton purchases 37 AvalonBay Communities Announces 37 - Operating [026] 37 STARLIMS filings 37 § #-#.# [001] 37 Macrovision assumes 37 asset impairments severance 37 satisfy indemnification obligations 37 Becancour facilities 37 polyphenylsulfone 37 liabilities# [001] 37 CHDT SEC Filings 37 mandatorily redeemable preferred 37 Cautionary Disclosures 37 - Operating [006] 37 NYCRR #.# d 37 Therics LLC 37 - Operating [019] 37 mitigants 37 iv IBC 37 Crisa 37 Adri Badenhorst Schalk Burger 37 en vertu de la 37 USC § #t 37 Nortel restatements 37 SAN FRANCISCO Narin Leininger 37 expressed orimplied 37 mmoore@equicomgroup.com 37 Furthermore ArQule 37 bone marrow fibrosis 37 INVESTING ACTIVITIES Purchase 37 intersegment purchases 37 e mail lifestyle@readingeagle.com 37 uncollectible accounts receivable 37 CFR § #.# [007] 37 - - Net [013] 37 R DYNACIN R 37 HealthTronics periodic filings 37 Partnered Brands segment 37 WNS ADS 37 gastrointestinal GVHD include 37 Chemed communications 37 Partial Tender Offer 37 Zemiva ™ 37 Asset impairment 37 - Loss [028] 37 franchisees licensees 37 § #.#.# [001] 37 includingstatements regarding 37 #.#-# Offeror Representations 37 products visit www.adm.com 37 excluding BIBP 37 -Maddur 37 provides CUSTOM FOLDING 37 Esterhazy Saskatchewan potash 37 Form# K 37 Symphony tCGM 37 Ron Klauda Maryland 37 obligations hereunder 37 # wQ 37 Pigments segment 37 DHL etcetera 37 Fukushima Daichi nuclear 37 incentive accruals 37 - Loss [023] 37 KEMET Announces 37 offuture 37 strategic reallocations 37 Oxandrin R 37 revise anyforward looking 37 Total noninterest 37 asset dispositions 37 - Loss [006] 37 resulting 37 Protonix ® 37 precision spindles 37 pY @ q 37 - - Income [025] 37 theforward looking 37 corporate reorganizations 37 @ vw 37 § #-#-# [002] 37 Immersion disclaims 37 en actions ordinaires 37 newproducts 37 NOL utilization 37 LIFO adjustments 37 PD2i Cardiac Analyzer 37 visit www.ethosfr.com 37 § #.# Vernon 37 askus@georgeson.com 37 COGP 37 exhibits hereto constitute 37 Including newbuildings 37 - Income [006] 37 Limited NNL 37 subsections b 37 PepsiCo bottling 37 -Brad Dorfman editing 37 Recommendation Statement 37 Termination Benefits 37 iaculis 37 Analysis C.1 Strengths 37 Innodata Isogen acquires 37 KRYSTEXXA TM 37 contemplated thereunder 37 XL# anticancer compounds 37 Bioaccelerate compounds under 37 Contingent Liabilities 37 Regeneron filings 37 - Income [007] 37 sequencing gene expression 36 Excess Cash Flow 36 - Income [020] 36 andfinancial 36 #.#-# [020] 36 prorations 36 de ses 36 Discontinuations due 36 derived therefrom 36 excludes unrealized gains 36 ti es 36 Westell accounting 36 cyclicality inherent 36 Dynegy cautions 36 iii Immtech ability 36 x fluctuating beryllium 36 Partially offsetting these 36 USC § #a c 36 respect thereto 36 VanceInfo filings 36 EnPro Industries Announces